D441 Objective Assessment – WGU
Pharmacology OA (2026) Complete
Question Bundle Guaranteed Pass
2026/2027 Edition
ABOUT THIS RESOURCE
This comprehensive study guide is based on the
WGU D441 Pharmacology Objective Assessment
for 2026/2027. It features actual exam-style
questions covering pharmacokinetics,
pharmacodynamics, drug classifications, adverse
effects, medication safety, and clinical application.
All questions are verified with correct answers and
detailed rationales to ensure exam success .
SECTION 1: PHARMACOKINETICS &
PHARMACODYNAMICS
1
,Question 1: Which process describes the movement
of a drug from its site of administration into the
bloodstream?
A) Distribution
B) Metabolism
C) Absorption
D) Excretion
Answer: C
Rationale: Absorption is the movement of a drug
from its site of administration into the blood.
Distribution is movement from blood to tissues,
metabolism is enzymatic alteration, and excretion is
removal from the body .
2
,Question 2: A client is prescribed a medication that
is known to be highly protein-bound. Which
statement about this medication is correct?
A) Only the free (unbound) drug is
pharmacologically active
B) The drug will have a shorter half-life
C) The drug will be excreted more rapidly
D) The drug will have a lower risk of drug
interactions
Answer: A
Rationale: Only the unbound (free) fraction of a drug
is pharmacologically active and able to exert its
therapeutic effect. Highly protein-bound drugs are at
risk for displacement interactions with other highly
protein-bound drugs .
3
, Question 3: The term "bioavailability" refers to:
A) The percentage of drug that is excreted
unchanged in the urine
B) The percentage of drug that reaches the systemic
circulation
C) The time it takes for the drug to reach peak
concentration
D) The volume of distribution of the drug
Answer: B
Rationale: Bioavailability is the fraction of an
administered dose of drug that reaches the systemic
circulation unchanged. An IV dose has 100%
bioavailability; oral drugs have variable
bioavailability due to first-pass metabolism .
4
Pharmacology OA (2026) Complete
Question Bundle Guaranteed Pass
2026/2027 Edition
ABOUT THIS RESOURCE
This comprehensive study guide is based on the
WGU D441 Pharmacology Objective Assessment
for 2026/2027. It features actual exam-style
questions covering pharmacokinetics,
pharmacodynamics, drug classifications, adverse
effects, medication safety, and clinical application.
All questions are verified with correct answers and
detailed rationales to ensure exam success .
SECTION 1: PHARMACOKINETICS &
PHARMACODYNAMICS
1
,Question 1: Which process describes the movement
of a drug from its site of administration into the
bloodstream?
A) Distribution
B) Metabolism
C) Absorption
D) Excretion
Answer: C
Rationale: Absorption is the movement of a drug
from its site of administration into the blood.
Distribution is movement from blood to tissues,
metabolism is enzymatic alteration, and excretion is
removal from the body .
2
,Question 2: A client is prescribed a medication that
is known to be highly protein-bound. Which
statement about this medication is correct?
A) Only the free (unbound) drug is
pharmacologically active
B) The drug will have a shorter half-life
C) The drug will be excreted more rapidly
D) The drug will have a lower risk of drug
interactions
Answer: A
Rationale: Only the unbound (free) fraction of a drug
is pharmacologically active and able to exert its
therapeutic effect. Highly protein-bound drugs are at
risk for displacement interactions with other highly
protein-bound drugs .
3
, Question 3: The term "bioavailability" refers to:
A) The percentage of drug that is excreted
unchanged in the urine
B) The percentage of drug that reaches the systemic
circulation
C) The time it takes for the drug to reach peak
concentration
D) The volume of distribution of the drug
Answer: B
Rationale: Bioavailability is the fraction of an
administered dose of drug that reaches the systemic
circulation unchanged. An IV dose has 100%
bioavailability; oral drugs have variable
bioavailability due to first-pass metabolism .
4
